Molecular prenatal diagnosis in families with fetal mitochondrial trifunctional protein mutations
Molecular prenatal diagnosis in families with fetal mitochondrial trifunctional protein mutations
复制标题
DOI:
10.1067/mpd.2001.111503
复制
发表时间:
2001-03-01
影响因子:
5.1
通讯作者:
Strauss, AW
中科院分区:
文献类型:
--
作者:
Ibdah, JA;Zhao, YW;Strauss, AW
Objectives: To evaluate the feasibility of molecular prenatal diagnosis in families with mitochondrial trifunctional protein (TFP) mutations and prospectively study the effects of fetal genotype on pregnancy outcome. TFP catalyzes the last 3 steps in mitochondrial long-chain fatty acid oxidation.Study design: We performed molecular prenatal diagnosis in 9 pregnancies, 8 in 6 families with isolated long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD) deficiency and one in a family with complete TFP deficiency. Analyses were performed on chorionic villous samples in 7 pregnancies and on amniocytes in 2.Results: Molecular prenatal diagnosis successfully identified the fetal genotype in all 9 pregnancies. Two fetuses were affected, and both pregnancies were terminated by family decision. Two other fetuses had normal genotype and 5 others were heterozygotes. These 7 pregnancies were uncomplicated, and all the offspring are alive and apparently healthy. Genotypes of the aborted fetuses and neonates were confirmed by molecular analysis and enzymatic assays.Conclusions: Molecular prenatal diagnosis is possible and valid in guiding management of pregnancies in families with known TFP defects. Women heterozygous for TFP alpha -subunit mutations who carry fetuses with wildtype or heterozygous genotypes have uncomplicated pregnancies.